Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2320976116', 'doi': 'https://doi.org/10.1056/nejme0906549', 'title': 'Ticagrelor — Is There Need for a New Player in the Antiplatelet-Therapy Field?', 'display_name': 'Ticagrelor — Is There Need for a New Player in the Antiplatelet-Therapy Field?', 'publication_year': 2009, 'publication_date': '2009-08-30', 'ids': {'openalex': 'https://openalex.org/W2320976116', 'doi': 'https://doi.org/10.1056/nejme0906549', 'mag': '2320976116', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/19717845'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1056/nejme0906549', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S62468778', 'display_name': 'New England Journal of Medicine', 'issn_l': '0028-4793', 'issn': ['0028-4793', '1533-4406'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320239', 'host_organization_name': 'Massachusetts Medical Society', 'host_organization_lineage': ['https://openalex.org/P4310320239'], 'host_organization_lineage_names': ['Massachusetts Medical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'letter', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5109603511', 'display_name': 'Albert Schömig', 'orcid': None}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': True, 'raw_author_name': 'Albert Schömig', 'raw_affiliation_strings': ['Department of Cardiology, Deutsches Herzzentrum and First Medizinische Klinik rechts der Isar, Munich, Germany.'], 'affiliations': [{'raw_affiliation_string': 'Department of Cardiology, Deutsches Herzzentrum and First Medizinische Klinik rechts der Isar, Munich, Germany.', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5109603511'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 131, 'citation_normalized_percentile': {'value': 0.999198, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 98, 'max': 99}, 'biblio': {'volume': '361', 'issue': '11', 'first_page': '1108', 'last_page': '1111'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11064', 'display_name': 'Antiplatelet Therapy and Cardiovascular Diseases', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11064', 'display_name': 'Antiplatelet Therapy and Cardiovascular Diseases', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T13489', 'display_name': 'Synthesis of β-Lactam Compounds', 'score': 0.9921, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T10285', 'display_name': 'Venous Thromboembolism Diagnosis and Management', 'score': 0.9895, 'subfield': {'id': 'https://openalex.org/subfields/2724', 'display_name': 'Internal Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/thienopyridine', 'display_name': 'Thienopyridine', 'score': 0.838732}, {'id': 'https://openalex.org/keywords/adenosine-diphosphate', 'display_name': 'Adenosine diphosphate', 'score': 0.5767049}], 'concepts': [{'id': 'https://openalex.org/C2777849778', 'wikidata': 'https://www.wikidata.org/wiki/Q410237', 'display_name': 'Clopidogrel', 'level': 3, 'score': 0.94589496}, {'id': 'https://openalex.org/C2780890252', 'wikidata': 'https://www.wikidata.org/wiki/Q420542', 'display_name': 'Ticagrelor', 'level': 4, 'score': 0.89607084}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8803185}, {'id': 'https://openalex.org/C49059817', 'wikidata': 'https://www.wikidata.org/wiki/Q14916330', 'display_name': 'P2Y12', 'level': 4, 'score': 0.84411883}, {'id': 'https://openalex.org/C2779837110', 'wikidata': 'https://www.wikidata.org/wiki/Q3074941', 'display_name': 'Thienopyridine', 'level': 4, 'score': 0.838732}, {'id': 'https://openalex.org/C89560881', 'wikidata': 'https://www.wikidata.org/wiki/Q101026', 'display_name': 'Platelet', 'level': 2, 'score': 0.7287477}, {'id': 'https://openalex.org/C2777399203', 'wikidata': 'https://www.wikidata.org/wiki/Q185253', 'display_name': 'Adenosine diphosphate', 'level': 4, 'score': 0.5767049}, {'id': 'https://openalex.org/C2777028646', 'wikidata': 'https://www.wikidata.org/wiki/Q416232', 'display_name': 'Prasugrel', 'level': 4, 'score': 0.53531694}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.50588006}, {'id': 'https://openalex.org/C140840227', 'wikidata': 'https://www.wikidata.org/wiki/Q3737532', 'display_name': 'CYP2C19', 'level': 4, 'score': 0.487763}, {'id': 'https://openalex.org/C164705383', 'wikidata': 'https://www.wikidata.org/wiki/Q10379', 'display_name': 'Cardiology', 'level': 1, 'score': 0.48394492}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.44330832}, {'id': 'https://openalex.org/C2780868729', 'wikidata': 'https://www.wikidata.org/wiki/Q261327', 'display_name': 'Thrombosis', 'level': 2, 'score': 0.416681}, {'id': 'https://openalex.org/C500558357', 'wikidata': 'https://www.wikidata.org/wiki/Q12152', 'display_name': 'Myocardial infarction', 'level': 2, 'score': 0.3917356}, {'id': 'https://openalex.org/C2993802102', 'wikidata': 'https://www.wikidata.org/wiki/Q101026', 'display_name': 'Platelet aggregation', 'level': 3, 'score': 0.1882982}, {'id': 'https://openalex.org/C526171541', 'wikidata': 'https://www.wikidata.org/wiki/Q407693', 'display_name': 'Cytochrome P450', 'level': 3, 'score': 0.14776367}, {'id': 'https://openalex.org/C62231903', 'wikidata': 'https://www.wikidata.org/wiki/Q1057', 'display_name': 'Metabolism', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D054058', 'descriptor_name': 'Acute Coronary Syndrome', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000241', 'descriptor_name': 'Adenosine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D010975', 'descriptor_name': 'Platelet Aggregation Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D058919', 'descriptor_name': 'Purinergic P2 Receptor Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D054058', 'descriptor_name': 'Acute Coronary Syndrome', 'qualifier_ui': 'Q000401', 'qualifier_name': 'mortality', 'is_major_topic': False}, {'descriptor_ui': 'D054058', 'descriptor_name': 'Acute Coronary Syndrome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000241', 'descriptor_name': 'Adenosine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000241', 'descriptor_name': 'Adenosine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000241', 'descriptor_name': 'Adenosine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077144', 'descriptor_name': 'Clopidogrel', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D010975', 'descriptor_name': 'Platelet Aggregation Inhibitors', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D010975', 'descriptor_name': 'Platelet Aggregation Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068799', 'descriptor_name': 'Prasugrel Hydrochloride', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013876', 'descriptor_name': 'Thiophenes', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D013876', 'descriptor_name': 'Thiophenes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077486', 'descriptor_name': 'Ticagrelor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013988', 'descriptor_name': 'Ticlopidine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D013988', 'descriptor_name': 'Ticlopidine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013988', 'descriptor_name': 'Ticlopidine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}, {'descriptor_ui': 'D013988', 'descriptor_name': 'Ticlopidine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1056/nejme0906549', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S62468778', 'display_name': 'New England Journal of Medicine', 'issn_l': '0028-4793', 'issn': ['0028-4793', '1533-4406'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320239', 'host_organization_name': 'Massachusetts Medical Society', 'host_organization_lineage': ['https://openalex.org/P4310320239'], 'host_organization_lineage_names': ['Massachusetts Medical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/19717845', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.61, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 11, 'referenced_works': ['https://openalex.org/W1553345686', 'https://openalex.org/W1985059672', 'https://openalex.org/W1995259829', 'https://openalex.org/W2076517423', 'https://openalex.org/W2105005467', 'https://openalex.org/W2128228188', 'https://openalex.org/W2140501627', 'https://openalex.org/W2147746835', 'https://openalex.org/W2152823642', 'https://openalex.org/W2169387542', 'https://openalex.org/W2470272844'], 'related_works': ['https://openalex.org/W3003908579', 'https://openalex.org/W2979889017', 'https://openalex.org/W2565381353', 'https://openalex.org/W2522148824', 'https://openalex.org/W2185577209', 'https://openalex.org/W2127586058', 'https://openalex.org/W2056724561', 'https://openalex.org/W2042883253', 'https://openalex.org/W2031499028', 'https://openalex.org/W1686411234'], 'abstract_inverted_index': {'The': [0, 60, 97], 'thienopyridine': [1], 'clopidogrel,': [2], 'which': [3], 'irreversibly': [4], 'blocks': [5], 'the': [6, 31, 75], 'adenosine': [7], 'diphosphate': [8], '(ADP)': [9], 'receptor': [10], 'P2Y12': [11], 'on': [12, 56], 'platelets,': [13], 'has': [14, 35], 'become': [15], 'an': [16, 91], 'essential': [17], 'component': [18], 'of': [19, 42, 52, 67, 77, 94], 'therapy': [20], 'in': [21, 47], 'patients': [22], 'with': [23, 84], 'acute': [24], 'coronary': [25, 95], 'syndromes,': [26], 'because': [27], 'it': [28], 'significantly': [29], 'improves': [30], 'outcomes.1': [32], 'However,': [33], 'clopidogrel': [34, 89], 'at': [36], 'least': [37], 'three': [38], 'drawbacks:': [39], 'delayed': [40], 'onset': [41], 'action,': [43], 'large': [44], 'interindividual': [45], 'variability': [46], 'platelet': [48], 'response,': [49], 'and': [50, 80], 'irreversibility': [51], 'its': [53], 'inhibitory': [54], 'effect': [55], 'platelets': [57], '(Figure': [58], '1).': [59], 'two-step': [61], 'activation': [62], 'process,': [63], 'involving': [64], 'a': [65, 85], 'series': [66], 'cytochrome': [68], 'P-450': [69], '(CYP)': [70], 'isoenzymes,': [71], 'is': [72], 'susceptible': [73], 'to': [74, 88], 'interference': [76], 'genetic': [78], 'polymorphisms2': [79], 'drug–drug': [81], 'interactions.3': [82], 'Patients': [83], 'poor': [86], 'response': [87], 'have': [90], 'increased': [92, 98], 'risk': [93, 99], 'thrombosis.4': [96], '.': [100, 101, 102]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2320976116', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 6}, {'year': 2021, 'cited_by_count': 2}, {'year': 2020, 'cited_by_count': 12}, {'year': 2019, 'cited_by_count': 7}, {'year': 2018, 'cited_by_count': 5}, {'year': 2017, 'cited_by_count': 11}, {'year': 2016, 'cited_by_count': 7}, {'year': 2015, 'cited_by_count': 11}, {'year': 2014, 'cited_by_count': 9}, {'year': 2013, 'cited_by_count': 8}, {'year': 2012, 'cited_by_count': 13}], 'updated_date': '2024-12-07T06:44:03.357884', 'created_date': '2016-06-24'}